Cita APA (7a ed.)
Maremmani, I., Dematteis, M., Gorzelanczyk, E. J., Mugelli, A., Walcher, S., & Torrens, M. (2023). Long-acting buprenorphine formulations as a new strategy for the treatment of opioid use disorder. MDPI.
Cita Chicago Style (17a ed.)
Maremmani, Icro, Maurice Dematteis, Edward J. Gorzelanczyk, Alessandro Mugelli, Stephan Walcher, y Marta Torrens. Long-acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. MDPI, 2023.
Cita MLA (9a ed.)
Maremmani, Icro, et al. Long-acting Buprenorphine Formulations as a New Strategy for the Treatment of Opioid Use Disorder. MDPI, 2023.
Precaución: Estas citas no son 100% exactas.